Palatin Technologies, in partnership with King Pharmaceuticals, is in middle-stage trials (Phase II of a total of three) to research another nasal-sprayed chemical, PT-141, which stimulates the hypothalamus' melanocortin receptors, which are responsible for hunger and may have a more potent arousal effect.

FORBES: Health

PT-141 (short for Palatin Technologies) works very differently: It interacts with melanocortin receptors in the brain, nerves involved in sexual arousal.

FORBES: A novel way, perhaps, to treat sexual dysfunction.

PT-141 (short for Palatin Technologies) works very differently: It interacts with melanocortin receptors in the brain, nerves involved in everything from regulating appetite to sexual arousal.

FORBES: Who Needs Coppertone?